What plan was used for the recent INGN insider share acquisition?

The filing states that the 1,500 shares of Inogen common stock were acquired through the company’s 2014 Employee Stock Purchase Plan.

Inogen VP, CAO buys 1,500 shares at $5.33

Q: Is the INGN insider transaction a purchase or a sale of shares?

The Form 4 reports an acquisition of 1,500 shares of Inogen common stock by Mary E. Wright. No sales or dispositions are reported in this filing.

Inogen’s Chief Accounting Officer increased her direct common stock holdings through a purchase under the 2014 Employee Stock Purchase Plan.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Inogen Inc (INGN) reported that Mary E. Wright, its Vice President and Chief Accounting Officer, acquired 1,500 shares of Inogen common stock on September 1, 2026. The shares were acquired through the company’s 2014 Employee Stock Purchase Plan, bringing her directly held stake to 20,629 shares.

Insider Trade Summary

Grant/Award: 1,500 shares

Grant/Award 1 txn

Insider Wright Mary E

Role VP, Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock ^F1	1,500	$5.33	$8K

Holdings After Transaction: Common Stock — 20,629 shares (Direct)

Footnotes (1)

F1. Shares acquired through the Company's 2014 Employee Stock Purchase Plan.

Key Figures

Shares acquired: 1,500 shares Acquisition price per share: $5.33 per share Shares owned after transaction: 20,629 shares

3 metrics

Shares acquired 1,500 shares Common stock acquired on September 1, 2026

Acquisition price per share $5.33 per share Price for shares acquired on September 1, 2026

Shares owned after transaction 20,629 shares Directly held by Mary E. Wright following the acquisition

Key Terms

2014 Employee Stock Purchase Plan

1 terms

2014 Employee Stock Purchase Plan financial

"Shares acquired through the Company's 2014 Employee Stock Purchase Plan"

FAQ

What insider transaction did Inogen Inc (INGN) report for Mary E. Wright?

Inogen reported that Mary E. Wright, VP and Chief Accounting Officer, acquired 1,500 shares of its common stock on September 1, 2026 through the company’s 2014 Employee Stock Purchase Plan.

At what price were the new INGN shares acquired by the officer?

Mary E. Wright acquired the 1,500 Inogen common shares at a price of $5.33 per share, as reported in the Form 4 insider filing.

How many INGN shares does Mary E. Wright hold after this transaction?

After the reported acquisition, Mary E. Wright directly holds 20,629 shares of Inogen common stock, according to the Form 4 filing.

Was the INGN insider transaction made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that the September 1, 2026 acquisition was made pursuant to a Rule 10b5-1 trading plan.

Is the INGN insider transaction a purchase or a sale of shares?

The Form 4 reports an acquisition of 1,500 shares of Inogen common stock by Mary E. Wright. No sales or dispositions are reported in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/03/2026 - 05:10 PM Accepted by SEC EDGAR 09/03/2026 - 05:02 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wright Mary E

(Last)

(First)

(Middle)

C/O INOGEN, INC.

500 CUMMINGS CENTER, SUITE 2800

(Street)

BEVERLY

MASSACHUSETTS

01915

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inogen Inc [ INGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/01/2026		A		1,500⁽¹⁾	A	$5.33	20,629	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares acquired through the Company's 2014 Employee Stock Purchase Plan.

	/s/ Mary Wright	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR